Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

Trial Profile

Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Mallinckrodt Inc.
  • Most Recent Events

    • 06 Nov 2016 Status changed from recruiting to withdrawn prior to enrolment.
    • 13 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top